You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 2
  • O02 First in man study of OTR4132, a heparan sulfate mimetic neuroprotector, injected intra-arterially after endovascular thrombectomy in patients with acute ischemic stroke: the matriss trial

Citation Tools

Article menu

Download PDFPDF

Abstracts
Ischemic
2.3. Treatment
O02 First in man study of OTR4132, a heparan sulfate mimetic neuroprotector, injected intra-arterially after endovascular thrombectomy in patients with acute ischemic stroke: the matriss trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Barreau X, Anxionnat R, Heck O, et al
O02 First in man study of OTR4132, a heparan sulfate mimetic neuroprotector, injected intra-arterially after endovascular thrombectomy in patients with acute ischemic stroke: the matriss trial
Journal of NeuroInterventional Surgery 2024;16:A1-A2.